Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$37,051,594
+$11,690,777 QoQ
Shares Held
30,891
+12.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#629
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS FINANCIAL LLC holds $153,520,894 across 14 Drug Manufacturers - General names. LLY ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
30,891 | $37,051,594 | |
| 2 | JNJ |
Johnson & Johnson
|
139,478 | $35,423,227 | |
| 3 | ABBV |
AbbVie Inc.
|
132,877 | $33,437,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,087 | $25,839,679 | |
| 5 | AMGN |
Amgen Inc
|
17,422 | $6,308,854 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
104,335 | $6,011,782 | |
| 7 | PFE |
Pfizer Inc
|
153,898 | $3,705,863 | |
| 8 | AZN |
Astrazeneca PLC
|
13,070 | $2,478,333 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,051,594 | 30,891 | Shares | Defined | 2026-07-17 | |
| 2026-03-31 | $25,360,817 | 27,573 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $30,674,593 | 28,543 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,402,913 | 28,051 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $19,528,784 | 25,052 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,429,060 | 25,946 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $20,333,708 | 26,339 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||